Advertisement
Screener

Can-Fite BioPharma Ltd. (CANF) Form 6-K: Report of foreign private issuer, 2021

1.0 / 5 stars · 8/40 Roast Me

Add as a preferred source on Google

Can-Fite BioPharma Ltd. Form 6-K: Report of foreign private issuer

Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.

  • 2021-12-29: Form 6-K; Period of report 2021-12-29; Description REPORT OF FOREIGN PRIVATE ISSUER; Document ea153131-6k_canfite.htm.
  • 2021-12-23: Form 6-K; Period of report 2021-12-23; Description REPORT OF FOREIGN PRIVATE ISSUER; Document ea152948-6k_canfitebiopharma.htm.
  • 2021-12-20: Form 6-K; Period of report 2021-12-20; Description CURRENT REPORT; Document ea152743-6k_canfite.htm.
  • 2021-12-20: Form 6-K; Period of report 2021-12-20; Description REPORT OF FOREIGN PRIVATE ISSUER; Document ea152660-6k_canfitebio.htm.
FiledFormPeriod of reportDescriptionDocument
2021-12-296-K2021-12-29REPORT OF FOREIGN PRIVATE ISSUERea153131-6k_canfite.htm
2021-12-236-K2021-12-23REPORT OF FOREIGN PRIVATE ISSUERea152948-6k_canfitebiopharma.htm
2021-12-206-K2021-12-20CURRENT REPORTea152743-6k_canfite.htm
2021-12-206-K2021-12-20REPORT OF FOREIGN PRIVATE ISSUERea152660-6k_canfitebio.htm
2021-12-076-K2021-12-07REPORT OF FOREIGN PRIVATE ISSUERea151855-6k_canfitebio.htm
2021-11-266-K2021-11-26REPORT OF FOREIGN PRIVATE ISSUERea151408-6k_canfitebio.htm
2021-11-236-K2021-11-23REPORT OF FOREIGN PRIVATE ISSUERea151252-6k_canfitebio.htm
2021-10-286-K2021-10-28REPORT OF FOREIGN PRIVATE ISSUERea149515-6k_canfitebio.htm
2021-10-216-K2021-10-21REPORT OF FOREIGN PRIVATE ISSUERea149226-6k_canfitebio.htm
2021-09-026-K2021-09-02REPORT OF FOREIGN PRIVATE ISSUERea146844-6k_canfitebio.htm
2021-08-266-K2021-06-30REPORT OF FOREIGN PRIVATE ISSUERea146356-6k_canfite.htm
2021-08-166-K2021-08-16REPORT OF FOREIGN PRIVATE ISSUERea145842-6k_canfitebio.htm
2021-08-126-K2021-08-12CURRENT REPORTea145651-6k_canfitebio.htm
2021-08-056-K2021-08-05CURRENT REPORT OF PRIVATE ISSUERea145292-6k_canfite.htm
2021-07-296-K2021-07-29REPORT OF FOREIGN PRIVATE ISSUERea144949-6k_canfitebio.htm
2021-07-086-K2021-07-08REPORT OF FOREIGN PRIVATE ISSUERea143896-6k_canfitebio.htm
2021-06-286-K2021-06-28REPORT OF FOREIGN PRIVATE ISSUERea143373-6k_canfitebio.htm
2021-06-236-K2021-06-22CURRENT REPORTea143066-6k_canfite.htm
2021-06-166-K2021-06-16REPORT OF FOREIGN PRIVATE ISSUERea142816-6k_canfitebio.htm
2021-06-146-K2021-06-14FORM 6-Kea142695-6k_canfitebio.htm
2021-06-076-K2021-06-07FORM 6-Kea142308-6k_canfite.htm
2021-06-026-K2021-06-02REPORT OF FOREIGN PRIVATE ISSUERea142055-6k_canfitebio.htm
2021-06-016-K2021-06-01REPORT OF FOREIGN PRIVATE ISSUERea141961-6k_canfitebio.htm
2021-05-276-K2021-05-27REPORT OF FOREIGN PRIVATE ISSUERea141673-6k_canfitebio.htm
2021-04-296-K2021-04-29CURRENT REPORTea140071-6k_canfite.htm
2021-04-236-K2021-04-23REPORT OF FOREIGN PRIVATE ISSUERea139816-6k_canfitebio.htm
2021-04-226-K2021-04-22REPORT OF FOREIGN PRIVATE ISSUERea139795-6k_canfitebiopharma.htm
2021-04-206-K2021-04-20REPORT OF FOREIGN PRIVATE ISSUERea139701-6k_canfitebio.htm
2021-04-056-K2021-04-05REPORT OF FOREIGN PRIVATE ISSUERea139002-6k_canfitebio.htm
2021-03-306-K2021-03-30REPORT OF FOREIGN PRIVATE ISSUERea138630-6k_canfite.htm
2021-03-256-K2021-03-25CURRENT REPORTea138394-6k_canfite.htm
2021-03-186-K2021-03-18REPORT OF FOREIGN PRIVATE ISSUERea137976-6k_canfitebio.htm
2021-03-166-K2021-03-16REPORT OF FOREIGN PRIVATE ISSUERea137701-6k_canfitebiopharma.htm
2021-03-056-K2021-03-05REPORT OF FOREIGN PRIVATE ISSUERea137071-6k_canfitebioph.htm
2021-02-226-K2021-02-22REPORT OF FOREIGN PRIVATE ISSUERea136179-6k_canfitebiopharma.htm
2021-02-016-K2021-02-01REPORT OF FOREIGN PRIVATE ISSUERea134282-6k_canfitebio.htm
2021-01-286-K2021-01-28REPORT OF FOREIGN PRIVATE ISSUERea134122-6k_canfitebiopharma.htm
2021-01-086-K2021-01-08REPORT OF FOREIGN PRIVATE ISSUERea132964-6k_canfite.htm
Advertisement